A protein at the heart of heart disease
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 22-Jul-2025 08:10 ET (22-Jul-2025 12:10 GMT/UTC)
Low-density lipoproteins (LDL) — commonly known as bad cholesterol — have long been on scientists’ radar as a major contributor to heart disease. But these microscopic troublemakers have hidden their inner workings behind a maze of complexity. That is, until now.
In a new study published in Nature, University of Missouri researchers have, for the first time, revealed the specific shape and structure of one of the body’s most important yet complicated proteins: ApoB100. Acting as a kind of molecular exoskeleton, this protein wraps around LDL particles, allowing them to travel through the bloodstream, researchers found.
Research has revealed clear evidence that changes in the orchestration of brain oxygenation dynamics and neuronal function in Alzheimer’s disease contribute to the neurodegeneration.
The study “Neurovascular phase coherence is altered in Alzheimer’s Disease” is published in Brain Communications. Researchers found that the median respiration rate was approximately 13 breaths per minute for the control group, and approximately 17 breaths per minute for the Alzheimer’s group.
Prof Stefanovska said: This is a revolutionary discovery that may open a whole new world in the study of the Alzheimer's disease. It most likely reflects an inflammation, maybe in the brain, that once detected can probably be treated and severe states of Alzheimer's might be prevented in the future.”
The risk of being admitted to the hospital with heart disease is twice as high the year after birth for mothers of twins compared to singleton births, according to research published in the European Heart Journal. The risk is even higher in mothers of twins who had a high blood pressure condition during pregnancy.
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was compared to usual treatment with a beta-blocker according to a new study published in the journal Heart from the University of Birmingham, the city where digoxin was first used in 1785.